Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome

L. Sokol, L. Cripe, H. Kantarjian, M. A. Sekeres, S. Parmar, P. Greenberg, S. L. Goldberg, V. Bhushan, J. Shammo, Raymond Hohl, A. Verma, G. Garcia-Manero, Y. P. Li, A. Lowe, J. Zhu, A. F. List

Research output: Contribution to journalLetter

20 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)977-980
Number of pages4
JournalLeukemia
Volume27
Issue number4
DOIs
StatePublished - Apr 1 2013

Fingerprint

Drug Dose Response Relationship
Mitogen-Activated Protein Kinase 14
Indoles
Myelodysplastic Syndromes
Protein Kinase Inhibitors
SCIO-469

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Sokol, L., Cripe, L., Kantarjian, H., Sekeres, M. A., Parmar, S., Greenberg, P., ... List, A. F. (2013). Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome. Leukemia, 27(4), 977-980. https://doi.org/10.1038/leu.2012.264
Sokol, L. ; Cripe, L. ; Kantarjian, H. ; Sekeres, M. A. ; Parmar, S. ; Greenberg, P. ; Goldberg, S. L. ; Bhushan, V. ; Shammo, J. ; Hohl, Raymond ; Verma, A. ; Garcia-Manero, G. ; Li, Y. P. ; Lowe, A. ; Zhu, J. ; List, A. F. / Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome. In: Leukemia. 2013 ; Vol. 27, No. 4. pp. 977-980.
@article{3487a3c84702404096951e70983b93f0,
title = "Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome",
author = "L. Sokol and L. Cripe and H. Kantarjian and Sekeres, {M. A.} and S. Parmar and P. Greenberg and Goldberg, {S. L.} and V. Bhushan and J. Shammo and Raymond Hohl and A. Verma and G. Garcia-Manero and Li, {Y. P.} and A. Lowe and J. Zhu and List, {A. F.}",
year = "2013",
month = "4",
day = "1",
doi = "10.1038/leu.2012.264",
language = "English (US)",
volume = "27",
pages = "977--980",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "4",

}

Sokol, L, Cripe, L, Kantarjian, H, Sekeres, MA, Parmar, S, Greenberg, P, Goldberg, SL, Bhushan, V, Shammo, J, Hohl, R, Verma, A, Garcia-Manero, G, Li, YP, Lowe, A, Zhu, J & List, AF 2013, 'Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome', Leukemia, vol. 27, no. 4, pp. 977-980. https://doi.org/10.1038/leu.2012.264

Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome. / Sokol, L.; Cripe, L.; Kantarjian, H.; Sekeres, M. A.; Parmar, S.; Greenberg, P.; Goldberg, S. L.; Bhushan, V.; Shammo, J.; Hohl, Raymond; Verma, A.; Garcia-Manero, G.; Li, Y. P.; Lowe, A.; Zhu, J.; List, A. F.

In: Leukemia, Vol. 27, No. 4, 01.04.2013, p. 977-980.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome

AU - Sokol, L.

AU - Cripe, L.

AU - Kantarjian, H.

AU - Sekeres, M. A.

AU - Parmar, S.

AU - Greenberg, P.

AU - Goldberg, S. L.

AU - Bhushan, V.

AU - Shammo, J.

AU - Hohl, Raymond

AU - Verma, A.

AU - Garcia-Manero, G.

AU - Li, Y. P.

AU - Lowe, A.

AU - Zhu, J.

AU - List, A. F.

PY - 2013/4/1

Y1 - 2013/4/1

UR - http://www.scopus.com/inward/record.url?scp=84876114118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876114118&partnerID=8YFLogxK

U2 - 10.1038/leu.2012.264

DO - 10.1038/leu.2012.264

M3 - Letter

C2 - 23032694

AN - SCOPUS:84876114118

VL - 27

SP - 977

EP - 980

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 4

ER -